Nebraska Methodist Health System — Omaha, Nebraska

Nebraska Methodist Health System is a clinical research site located in Omaha, Nebraska, United States 68114.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Nebraska Methodist Health System has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Pancreatic Cancer, Thyroid Cancer, Lung Cancer.

Sponsors: University of Nebraska.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nebraska Methodist Health System?

Nebraska Methodist Health System has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nebraska Methodist Health System conducted?

Nebraska Methodist Health System has 1 clinical trials on record, with 1 currently active. Their work covers Pancreatic Cancer, Thyroid Cancer, Lung Cancer.

Is Nebraska Methodist Health System accredited by Crixeo Health?

Nebraska Methodist Health System has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nebraska Methodist Health System?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.